Original Research Article
Cerebral Amyloid Angiopathy in Alzheimer's Disease: Clinicopathological CorrelationsLopez O.L.a,b · Claassen D.b,c
a Department of Neurology and Psychiatry, b Pittsburgh Alzheimer's Disease Research Center, and c Department of Pathology, Division of Neuropathology, University of Pittsburgh School of Medicine, Pittsburgh, Pa., USA
Do you have an account?
- Rent for 48h to view
- Buy Cloud Access for unlimited viewing via different devices
- Synchronizing in the ReadCube Cloud
- Printing and saving restrictions apply
Rental: USD 8.50
Cloud: USD 20.00
The presence of cerebral amyloid angiopathy (CAA) in capillaries and arterioles of the cerebral and cerebellar cortex of Alzheimer's disease (AD) patients may provide an opportunity to study the clinical significance of these vascular changes in AD. We reviewed the clinical and pathological features of 40 patients with AD without other CNS disease. The sections were examined by the red Congo method under a polarized light for the presence of CAA. Twenty-two (55%) had AD + CAA. CAA was seen most frequently and was of greater severity in occipital and frontal gray matter. We concluded that it is not possible to differentiate between AD patients with CAA and those without CAA in terms of demographic characteristics and neurological and psychiatric symptomatology.
© 1991 S. Karger AG, Basel
Article / Publication Details
Copyright / Drug Dosage / DisclaimerCopyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.